| Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325) |
|---|
| 03/25/2008 | US7348438 Benzimidazole derivatives useful as selective androgen receptor modulators (SARMS) |
| 03/25/2008 | US7348326 in brain; (2,5-difluorodifluorophenyl)-N-methyl-N-((1-propylbenzimidazol-2-yl)methyl)carboxamide; anxiolitic and antidepressant; finding and altering the signal-transducing activity of gamma aminobutyric acid (GABA) receptors; detectably-labeled antagonist/agonist of GABAR |
| 03/25/2008 | CA2277273C Integrin antagonists |
| 03/20/2008 | WO2008031743A1 Heterocyclic bridged biphenyls and their use in oleds |
| 03/20/2008 | WO2008031509A1 ISOSERINE DERIVATIVES FOR USE AS COAGULATION FACTOR IXa INHIBITORS |
| 03/20/2008 | WO2008031508A1 TARTRATE DERIVATIVES FOR USE AS COAGULATION FACTOR IXa INHIBITORS |
| 03/20/2008 | WO2007144769A3 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics |
| 03/20/2008 | US20080070948 Including indanones, indolinones and benzoxazolinones containing a piperidine ring, e.g., 1-[3-(4-(Hydroxymethyl)piperidin-1-yl)propyl]-1,3-dihydrobenzoimidazol-2-one; particularly for the M1 and/or M4 receptor subtypes; increase acetylcholine signaling or effect in the brain |
| 03/20/2008 | CA2663544A1 Isoserine derivatives for use as coagulation factor ixa inhibitors |
| 03/20/2008 | CA2663543A1 Tartrate derivatives for use as coagulation factor ixa inhibitors |
| 03/20/2008 | CA2663189A1 Benzimidazolone derivatives |
| 03/19/2008 | EP1899309A1 Heterocyclic compounds as agonists for the thyroid receptor |
| 03/19/2008 | EP1899299A2 C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 03/19/2008 | CN100375743C Method for preparing 2-trifluoro methyl benzimidazole |
| 03/18/2008 | US7345075 1,2 diarylbenzimidazoles and their pharmaceutical use |
| 03/18/2008 | US7345074 Derivatives of [6,7-dihydro-5H-imidazol[1,2-a]imidazole-3-sulfonylamino]-propionamide |
| 03/18/2008 | US7345068 Aromatic amino acid derivatives and medicinal compositions |
| 03/18/2008 | US7345050 Imidazo(1,2a)pyridine or pyrazolo(2,3a)pyridine derivatives; Alzheimer's and Parkinson's Disease; nervous system, brain, and psychological disorders |
| 03/18/2008 | CA2315927C Oral pharmaceutical pulsed release dosage form |
| 03/13/2008 | WO2008003752A8 2 -amino benzimidazole derivatives and their use as modulators of small - conductance calcium -act ivated potassium channels |
| 03/13/2008 | WO2007107311A3 Organic sulphinic acid derivatives |
| 03/13/2008 | US20080064733 MAGIs (membrane associated guanylate kinase proteins with inverse orientation); oncosuppressive (tumor suppressor) protein; (2-(1-Hydroxypentyl)-3-(2-phenylethyl)-6-methyl)indole-5-carboxylic acid |
| 03/13/2008 | US20080064731 Remedy for chronic disease |
| 03/13/2008 | US20080064690 Neuropathic or inflammatory pain relief; inhibiting ion flux through channel including PN3 subunit; potency |
| 03/13/2008 | US20080064687 Vanilloid receptor modulators; analgesic, antiinflammatory and antiulcer effects; such as 1-(1H-indol-5-ylmethyl)-3-phenethylthiourea |
| 03/13/2008 | DE112004000920T5 Polymerelektrolytmembranen (PEMS) beruhend auf von Imidazolring terminierten, auf Hybride anorganisch-organische Polymere gepfropften flexibeln Zweigen Polymer electrolyte membranes (PEMS) based on the imidazole ring of terminated grafted on hybrid inorganic-organic polymers flexibeln branches |
| 03/12/2008 | EP1896450A1 2-substituted benzimidazoles |
| 03/12/2008 | EP1896427A2 Novel 2-(phenylamino)benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels |
| 03/12/2008 | EP1534275B1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 03/12/2008 | CN101142194A Benzazole derivatives, compositions, and methods of use as b-secretase inhibitors |
| 03/12/2008 | CN101142193A Propane-1,3-dion derivative or salt thereof |
| 03/12/2008 | CN101139346A Benzimidazole-derivatives as factor Xa inhibitors |
| 03/12/2008 | CN100374424C Heterocyclic amide derivative and use as pesticide |
| 03/11/2008 | US7341700 Method for recovery of metals from metal-containing materials using medium temperature pressure leaching |
| 03/11/2008 | CA2237297C Process for the preparation of (1s,4r)-or(1r,4s)-4-(2-amino-6-chloro-9h-purin-9-yl)-2-cyclopentene-1-methanol |
| 03/11/2008 | CA2192764C Integrin receptor antagonists |
| 03/06/2008 | WO2008025736A1 Substituted benzimidazolone derivatives, medicaments comprising them and their use |
| 03/06/2008 | US20080058531 shades and excellent coloring properties; results from a coupling reaction of diazotized 4-(4'-aminobenzoylamino)benzamide with 5-acetoacetylaminobenzimidazolone (acetolone) |
| 03/06/2008 | US20080058382 Polyamine compounds |
| 03/06/2008 | US20080058349 Cognitive impairment, Alzheimer's Disease, neurodegeneration and dementia; Beta site APP Cleaving Enzyme (BACE) inhibitors; beta-secretase inhibitors; 3,3-Difluoro-8-(2',6-difluoro-3'-methoxybiphenyl-3-yl)-8-pyridin-4-yl-2,3,4,8-tetrahydroimidazo[1,5-a]pyrimidin-6-amine acetate for example |
| 03/06/2008 | CA2661870A1 Substituted benzimidazolone derivatives, medicaments comprising them and their use for treating vasopressin-dependent disease |
| 03/05/2008 | EP1893588A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 03/05/2008 | EP1893583A1 Substituted aryloxy-n-bicyclomethyl acetamide compounds as vr1 antagonists |
| 03/05/2008 | EP1893196A1 Diarylhydantoin compounds |
| 03/05/2008 | EP1637567B1 Benzimidazolone compound |
| 03/05/2008 | CN101137627A Process for the preparation of substituted benzoxazole compounds |
| 03/05/2008 | CN101134745A Nitric oxide donator type telmisartan derivant, preparation method and medical uses thereof |
| 03/05/2008 | CN101134744A Heterocyclic compound, the function, organic semiconductor material and electronic or opto-electrical element |
| 03/05/2008 | CN100372852C Synthesis of temozolomide and analogs |
| 03/05/2008 | CN100372846C Sulfonamido substituted imidazopyridines |
| 03/04/2008 | US7338956 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 02/28/2008 | WO2008023720A1 Urea compound or salt thereof |
| 02/28/2008 | US20080051423 Nitrogen heterocycle biaryls for osteoporosis and other diseases |
| 02/28/2008 | CA2665804A1 Urea compound or salt thereof |
| 02/27/2008 | EP1892245A2 Antineoplastic compounds and pharmaceutical compositions thereof |
| 02/27/2008 | EP1891053A1 Method for obtaining benzimidazole derivatives and intermediates thereof |
| 02/27/2008 | EP1891017A1 Nitrogen heterocycle biaryls for osteoporosis and other diseases |
| 02/27/2008 | EP1248612B1 Novel compounds and compositions as protease inhibitors |
| 02/27/2008 | CN101133036A Novel benzimidazole derivatives useful as selective androgen receptor modulators (SARMS) |
| 02/27/2008 | CN100371328C Substituted benzoyl carbamidine derivative, its preparation method and medical uses |
| 02/26/2008 | US7335777 Benzimidazole derivatives and their use for modulating the GABAA receptor complex |
| 02/21/2008 | WO2008019477A1 Viral polymerase inhibitors |
| 02/21/2008 | US20080045720 Reacting a naphthalenecarboxylic acid halide compound with ammonium acetate in a solvent such as tetrahydrofuran; high yield and at low cost; as chemical intermediates in producing dyes such as azo dyes, medical and agricultural chemicals |
| 02/21/2008 | US20080045516 Viral Polymerase Inhibitors |
| 02/21/2008 | CA2660555A1 Viral polymerase inhibitors |
| 02/20/2008 | EP1888568A2 Substituted benzimidazole compounds with dual nos inhibitory activity and muopioid agonist activity |
| 02/20/2008 | EP1432417B1 Substituted benzimidazole compounds and their use for the treatment of cancer |
| 02/20/2008 | CN101128452A Novel benzoimidazole derivatives and a pharmaceutical composition comprising the same |
| 02/20/2008 | CN101128421A Methods and compositions for treating amyloid-related diseases |
| 02/20/2008 | CN100369915C 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl derivatives with antipsychotic activity |
| 02/19/2008 | US7332613 use for quantitative protein expression profiling; reagent for mass spectrometric analysis of proteins comprising a tag molecule with a reactive site for stably associating with a protein, an isotope label, and a biotin compound linked to the tag through a pH or reducing agent sensitive bond |
| 02/19/2008 | US7332608 Potassium channel modulators; cardiovascular disorders; antiarrhythmia agents; synthesis |
| 02/14/2008 | WO2008018827A1 Benzimidazole derivatives useful in treatment of vallinoid receptor trpv1 related disorders |
| 02/14/2008 | WO2008017840A1 Cyclopentanecarboxylic acid derivatives and their use in the treatment of bacterial infectious diseases |
| 02/14/2008 | WO2007130780A3 Benzimidazole modulators of vr1 |
| 02/14/2008 | US20080038242 sodium-dependent nucleoside transporter 2 inhibitors; for diseases associated with abnormal plasma uric acid levels such as gout, hyperuricemia, urinary lithiasis, hyperuriciemic nephropathy, and acute uric acid nephropathy |
| 02/14/2008 | US20080038191 Radiolabeled Compounds And Compositions, Their Precursors And Methods For Their Production |
| 02/13/2008 | EP1885725A1 Tricyclic azole derivatives, their manufacture and use as pharmaceutical agents |
| 02/13/2008 | CN101124207A Benzimidazole acetic acids exhibiting CRTH2 receptor antagonism and uses thereof |
| 02/12/2008 | US7329684 Modulators of the receptor for advanced glycated end products and interact with its ligands; antiinflammatory, antidiabetic and antitumor agents; Alzheimer's disease, erectile dysfunction, metastasis; 2-[(1R)-2-(4-Benzyloxyphenyl)-1-amino-1-ethyl]-3-butyl-5-(3-diethylamino-1-propoxy)benzimidazole |
| 02/12/2008 | US7329675 Substituted azabicyclic compounds |
| 02/12/2008 | CA2315261C Oral pharmaceutical extended release dosage form |
| 02/06/2008 | CN101120057A Phthalocyanine compound, process for producing the same and colored composition containing the phthalocyanine compound |
| 02/06/2008 | CN101119973A 2-(phenyl or heterocyclic)-1h-phenantrho[9,10-d]imidazoles as mpges-1 inhibitors |
| 02/06/2008 | CN101119968A Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1 |
| 02/05/2008 | US7326812 Arylsulfonamidobenzylic compounds |
| 02/05/2008 | US7326792 4,5-Diphenyl-2-amino-4,5-dihydro-imidazole derivatives useful as pharmaceutical agents in treatment or prevention of diseases having an inflammatory component, including inflammatory bowel disease, rheumatoid arthritis and diseases associated with central nervous system, such as Alzheimer's disease |
| 02/05/2008 | US7326791 Carboxylic acid amides, the preparation thereof, and their use as pharmaceutical compositions |
| 02/05/2008 | US7326789 E.g., 2-(4-Chloro-phenylsufonylamino)-4,5-dimethoxy-N-(4-(thiomorpholine-4-sulfonyl)-phenyl)-benzamide; cardiovascular disorders; hypotensive agents; angina pectoris, cardiac insufficiency, thrombolytic agents; atherosclerosis; activating soluble guanylate cyclase to adjust a disturbed cyclic GMP balance |
| 02/05/2008 | US7326695 Anti-bacterial agents based upon oxoanion binding |
| 02/05/2008 | CA2417635C Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 02/05/2008 | CA2402686C Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 02/05/2008 | CA2349227C Substituted 2-phenylbenzimidazoles, the production thereof and their use |
| 01/31/2008 | WO2008012782A2 Labelled analogues of halobenzamides as radiopharmaceuticals |
| 01/31/2008 | WO2007061849A3 Method of generating amorphous solid for water-insoluble pharmaceuticals |
| 01/31/2008 | US20080027068 Heterocyclic compounds and thrombopoietin receptor activators |
| 01/31/2008 | US20080027036 S1P receptor modulating compounds and use thereof |
| 01/31/2008 | US20080025915 Technetium-And Rhenium-Bis (Heteroaryl) Complexes, And Methods Of Use Thereof |
| 01/31/2008 | CA2657247A1 Compounds which modulate the cb2 receptor |
| 01/30/2008 | CN101115802A Coloring matter for anisotropic coloring matter film, composition comprising said coloring matter, anisotropic coloring matter film, and polarizing element |